Position in ARWR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,567,500
-$92,250 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EDGEWOOD MANAGEMENT LLC holds $409,477,253 across 8 Biotechnology names. ARWR ranks #2 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
905,129 | $404,176,303 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
25,000 | $1,567,500 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
35,000 | $1,184,050 | |
| 4 | ARMP |
Armata Pharmaceuticals, Inc.
|
100,000 | $1,024,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
10,000 | $564,900 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
50,000 | $486,000 | |
| 7 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
50,000 | $306,500 | |
| 8 | SEER |
Seer, Inc.
|
100,000 | $168,000 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,567,500 | 25,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,659,750 | 25,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,034,700 | 30,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $474,000 | 30,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $382,200 | 30,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $376,000 | 20,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $387,400 | 20,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $519,800 | 20,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $572,000 | 20,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $612,000 | 20,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $537,400 | 20,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $713,200 | 20,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $482,600 | 19,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $770,640 | 19,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $627,950 | 19,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $668,990 | 19,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $873,810 | 19,000 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,259,700 | 19,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,186,170 | 19,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,573,580 | 19,000 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,657,750 | 25,000 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,918,250 | 25,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,076,500 | 25,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,079,750 | 25,000 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $460,320 | 16,000 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||